LBA6 KRYSTAL-1: Adagrasib (MRTX849) as monotherapy or combined with cetuximab (Cetux) in patients (Pts) with colorectal cancer (CRC) harboring a KRASG12C mutation
Authors:
- J. WeissJWJ. Weiss
- R.D. YaegerRYR.D. Yaeger
- M.L. JohnsonMJM.L. Johnson
- A. SpiraASA. Spira
- S.J. KlempnerSKS.J. Klempner
- M.A. BarveMBM.A. Barve
- J.G. ChristensenJCJ.G. Christensen
- A. ChiACA. Chi
- H. Der-TorossianHDH. Der-Torossian
- K. VelasteguiKVK. Velastegui
- T. KheohTKT. Kheoh
- S-H.I. OuSOS-H.I. Ou
- 1 September 2021
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 32, S1294